Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study

MLA

de la Cruz-Merino, L., et al. Clinical Features of Serous Retinopathy Observed with Cobimetinib in Patients with BRAF-Mutated Melanoma Treated in the Randomized CoBRIM Study. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315668154&authtype=sso&custid=ns315887.

APA

de la Cruz-Merino, L., Di Guardo, L., Grob, J.-J., Venosa, A., Larkin, J., McArthur, G., Ribas, A., Ascierto, P., Evans, J., Gomez-Escobar, A., Barteselli, G., Eng, S., Hsu, J., Uyei, A., & Dreno, B. (2017). Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study.

Chicago

de la Cruz-Merino, L, L Di Guardo, J-J Grob, A Venosa, J Larkin, Ga McArthur, A Ribas, et al. 2017. “Clinical Features of Serous Retinopathy Observed with Cobimetinib in Patients with BRAF-Mutated Melanoma Treated in the Randomized CoBRIM Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315668154&authtype=sso&custid=ns315887.